Stocks · Healthcare · Medical - Devices
CeriBell, Inc. CBLL
$23.69 +0.34% Close, Oct 2, 2026 · NASDAQ · Market cap $898.9M
Strong growthStrong trend
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Over the past year the stock returned +104.9%, ahead of the S&P 500 by 89.9 percentage points.
- Revenue over the last four quarters was $102.0M, up 31.7% from a year earlier, slowing from 33.7% a quarter earlier.
- The stock is in an uptrend: above its 200-day average for 40 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 24%
- Revenue growth, 3-year CAGRTop 14%
- Revenue growth accelerationBottom 35%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 28%
- Gross marginTop 20%
- Operating marginBottom 33%
- Accruals (lower is better)Top 47%
- Interest coverBottom 18%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 49%
- Free-cash-flow yieldBottom 46%
- EBITDA / enterprise valueBottom 45%
- Sales / enterprise valueBottom 34%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 14%
- 6-month returnTop 34%
- 1-year return vs S&P 500Top 15%
- Distance from 52-week highTop 10%
- Trend checklist (0–4)Top 20%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 38%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 10%
- Upside to consensus price targetBottom 24%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 28%
- Maximum drawdown, 3 yearsTop 41%
- Beta vs S&P 500 (lower is better)Top 36%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 33.7% | 31.7% | ↓ |
| Gross margin | 87.8% | 88.9% | ↑ |
| Operating margin | -67.1% | -68.6% | ↓ |
| FCF margin | -50.0% | -55.2% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 31.7% | 33.7% | ↓ | Top 24% |
| Gross margin | 88.9% | 87.8% | ↑ | Top 20% |
| Operating margin | -68.6% | -67.1% | ↓ | Bottom 33% |
| Net margin | -64.7% | -63.8% | ↓ | — |
| Free-cash-flow margin | -55.2% | -50.0% | ↓ | — |
| Return on invested capital | -46.5% | — | Bottom 28% | |
| Revenue growth, 3-year CAGR | 50.9% | — | Top 14% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -7.2%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 16.1%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -1.8 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -38.6×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.64%
- Shareholder yield
- -0.64%
- Share count change, 1 year
- +4.8%
- Share count change, 3-year CAGR
- +17.7%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 10, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- -2.8%
- Average 2-day reaction, last 8
- +0.5%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $27.50
- Target vs current price
- +16.1%
- Analysts with a rating
- 4
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 10, 2026 | -8.2% | +2.6% | +24.0% | +31.4% | — |
| May 11, 2026 | -33.3% | -0.7% | -19.3% | -10.2% | -9.5% |
| Feb 24, 2026 | +16.3% | -0.5% | -9.2% | -5.0% | -15.2% |
| Nov 4, 2025 | +14.0% | -3.7% | +3.9% | +48.6% | +81.7% |
| Aug 5, 2025 | +5.0% | -1.0% | -20.4% | -25.0% | -15.8% |
| May 8, 2025 | +16.3% | +6.8% | +2.8% | +9.3% | -4.9% |
| Feb 25, 2025 | -25.0% | +0.4% | -3.2% | -17.2% | -28.5% |
| Nov 12, 2024 | -125.6% | -0.2% | -13.5% | +2.5% | -25.8% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.51 | -$0.47 | -8.2% | $28.1M |
| May 11, 2026 | -$0.52 | -$0.39 | -33.3% | $26.5M |
| Feb 24, 2026 | -$0.36 | -$0.43 | +16.3% | $24.8M |
| Nov 4, 2025 | -$0.37 | -$0.43 | +14.0% | $22.6M |
| Aug 5, 2025 | -$0.38 | -$0.40 | +5.0% | $21.2M |
| May 8, 2025 | -$0.36 | -$0.43 | +16.3% | $20.5M |
| Feb 25, 2025 | -$0.40 | -$0.32 | -25.0% | $18.5M |
| Nov 12, 2024 | -$1.85 | -$0.82 | -125.6% | $17.2M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 8.71× | — | — | Bottom 34% |
| Free-cash-flow yield | -6.27% | — | — | Bottom 46% |
| Earnings yield | -7.43% | — | — | Top 49% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 40
- Days above the 200-day average
- 40
- 50-day average slope (20 days)
- +9.9%
- 200-day average slope (20 days)
- +3.4%
- Distance from 50-day average
- +4.7%
- Distance from 200-day average
- +16.3%
- RSI (14)
- 49.0
- Relative volume
- 0.88×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 44.2%
- Volatility vs own 5-year history
- 14th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.90
- Correlation with S&P 500
- 0.25
- Current drawdown from 1-year high
- -5.4%
- Maximum drawdown, 3 years
- -63.9%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Dec 6, 2024 | Nov 4, 2025 | -63.9% | 227 days | Not yet recovered |
| Nov 7, 2024 | Nov 18, 2024 | -13.6% | 7 days | 10 days (Dec 3, 2024) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $898.9M
- EPS, diluted (TTM)
- -$1.76
- Revenue (TTM)
- $102.0M
- 52-week range
- $10.85 – $25.63
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Revenue | $25.9M | $45.2M | $65.4M | $89.1M |
| Gross profit | $21.5M | $38.2M | $56.8M | $78.3M |
| Operating income | -$36.0M | -$30.0M | -$39.7M | -$58.4M |
| Net income | -$37.2M | -$29.5M | -$40.5M | -$53.4M |
| EPS (diluted) | -$1.59 | -$1.26 | -$1.13 | -$1.46 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.2M | $18.5M | $20.5M | $21.2M | $22.6M | $24.8M | $26.5M | $28.1M |
| Net income | -$10.4M | -$12.6M | -$12.8M | -$13.6M | -$13.5M | -$13.5M | -$19.7M | -$19.3M |
| EPS (diluted) | -$0.31 | -$0.40 | -$0.36 | -$0.38 | -$0.37 | -$0.36 | -$0.52 | -$0.51 |
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Operating cash flow | -$32.0M | -$29.2M | -$35.0M | -$40.8M |
| Capital expenditure | -$516,000 | -$983,000 | -$1.3M | -$767,000 |
| Free cash flow | -$32.5M | -$30.1M | -$36.4M | -$41.6M |
| Dividends paid | $0 | $0 | $0 | $0 |
| Net share buybacks | $0 | $0 | $188.9M | $5.4M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $129.3M
- Total assets
- $166.3M
- Total liabilities
- $38.0M
- Total debt
- $21.9M
- Net debt
- -$10.8M
- Shareholders’ equity
- $128.3M
As of Jun 30, 2026 (filed Aug 10, 2026).
Short interest
- Shares sold short
- 1,818,916
- Days to cover
- 6.12
- Change vs previous report
- -4.6%
FINRA short interest, settlement date Sep 15, 2026.